A moment of truth for global health
暂无分享,去创建一个
[1] M. Goozner. Innovation in Biomedicine: Can Stem Cell Research Lead the Way to Affordability? , 2006, PLoS medicine.
[2] Fiona E. Murray,et al. Intellectual property. Enhanced: intellectual property landscape of the human genome. , 2005, Science.
[3] Thomas H Segall-Shapiro,et al. Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome , 2010, Science.
[4] T. Lancet. Evaluation: the top priority for global health , 2010, The Lancet.
[5] Gregory D. Graff,et al. The global stem cell patent landscape: implications for efficient technology transfer and commercial development , 2007, Nature Biotechnology.
[6] D. Sridhar,et al. Global health funding: how much, where it comes from and where it goes. , 2009, Health policy and planning.
[7] Gareth Jones,et al. Levels and trends in under-5 mortality, 1990–2008 , 2010, The Lancet.
[8] M. Heller,et al. Can Patents Deter Innovation? The Anticommons in Biomedical Research , 1998, Science.
[9] G. Yamey,et al. Financing Maternal and Child Health—What Are the Limitations in Estimating Donor Flows and Resource Needs? , 2010, PLoS medicine.
[10] Wilfried Weber,et al. Synthetic biology in the analysis and engineering of signaling processes. , 2010, Integrative biology : quantitative biosciences from nano to macro.
[11] C. Scott,et al. Challenges to human embryonic stem cell patents. , 2008, Cell stem cell.
[12] Margaret Chan,et al. Meeting the Demand for Results and Accountability: A Call for Action on Health Data from Eight Global Health Agencies , 2010, PLoS medicine.
[13] Katherine Leach-Kemon,et al. Financing of global health: tracking development assistance for health from 1990 to 2007 , 2009, The Lancet.